Other ingredients
Hypromellose; Water; Stearic Acid; Magnesium Stearate (Mg Stearate); Medium Chain Triglyceride Oil (MCT Oil); Silica; Microcrystalline Cellulose; Hypromellose; Water; Water; Purified
Image: NIH Office of Dietary Supplements, Dietary Supplement Label Database — No separate image reuse license stated
XYMOGEN
OSAplex
Capsule
Serving size2 Capsule(s); 1 Capsule(s)
Servings per containerNot listed
Package60 Packet(s); 180 Capsule(s)
Data retrievedJul 28, 2026
Supplement Facts
Serving size 2 Capsule(s); 1 Capsule(s)
Vitamin D50 mcg250% DV
Calcium550 mg42% DV
Phosphorus198 mg16% DV
Microcrystalline Hydroxyapatite Concentrate2.2 gDV not established
Microcrystalline Hydroxyapatite1.32 gDV not established
Label directions
Directions: Consume the contents of one packet with a meal; one to two times daily; or as directed by your healthcare professional.
Label warnings
Consult your healthcare professional prior to use. Do not use if packet is damaged. The labeling on this product does not comply with California's Proposition 65. Therefore this product may not be sold in California. Individuals taking medication should discuss potential interactions with their healthcare professional. Storage: Keep closed in a cool dry place out of reach of children.
Identity and label version
NIH label record335537
Entered into NIH DSLDSep 25, 2025
UPC / GTIN00871149002367
Manufacturer / distributor on labelXYMOGEN Exclusive Professional Formulas
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.
NIH label history (1)
Current labelNIH record 335537Entered Sep 25, 2025
Serving size2 Capsule(s); 1 Capsule(s)
Formula versionb777f80b
Ingredients on label5
NIH sourceOpen label ↗
Vitamin D50 mcg
Calcium550 mg
Phosphorus198 mg
Microcrystalline Hydroxyapatite Concentrate2.2 g
Microcrystalline Hydroxyapatite1.32 g
Label warning: Consult your healthcare professional prior to use. Do not use if packet is damaged. The labeling on this product does not comply with California's Proposition 65. Therefore this product may not be sold in California. Individuals taking medication should discuss potential interactions with their healthcare professional. Storage: Keep closed in a cool dry place out of reach of children.
Sources and traceability
- NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026Open source ↗
More from XYMOGEN
Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.